Below are the most recent publications written about "Neuropsychological Tests" by people in Profiles.
-
Ding H, Ye Z, Paschalidis A, Bennett DA, Au R, Lin H. Dynamic lifetime risk prediction of Alzheimer's disease with longitudinal cognitive assessment measurements. Alzheimers Dement. 2025 Mar; 21(3):e70055.
-
Schneider LS, Freiesleben SD, van Breukelen G, Wang X, Brosseron F, Heneka MT, Teipel S, Kleineidam L, Stark M, Roy-Kluth N, Wagner M, Spottke A, Schmid M, Roeske S, Laske C, Munk MH, Perneczky R, Rauchmann BS, Buerger K, Janowitz D, D?zel E, Glanz W, Jessen F, Rostamzadeh A, Wiltfang J, Bartels C, Kilimann I, Schneider A, Fliessbach K, Priller J, Spruth EJ, Hellmann-Regen J, Peters O. Linking higher amyloid beta 1-38 (A?(1-38)) levels to reduced Alzheimer's disease progression risk. Alzheimers Dement. 2025 Feb; 21(2):e14545.
-
Itsekson-Hayosh Z, Carpani F, Mosimann PJ, Agid R, Hendriks EJ, Radovanovic I, Barazarte HA, Schaafsma JD, Terbrugge K, Krings T, McAndrews MP, Nicholson P. Dural Arteriovenous Fistulas: Baseline Cognitive Changes and Changes following Treatment: A Prospective Longitudinal Study. AJNR Am J Neuroradiol. 2024 Dec 09; 45(12):1878-1884.
-
Zeamer AL, Sanborn V, Drake JD, Haran JP, Bucci V. Clinical Manifestations. Alzheimers Dement. 2024 Dec; 20 Suppl 3:e092640.
-
Stark M, Wagner M, Kuhn E, B?rger K, D?zel E, Hellmann-Regen J, Heneka MT, Laske C, Perneczky R, Peters O, Priller J, Schmid M, Schneider A, Spottke A, Teipel S, Wiltfang J, Jessen F, Kleineidam L. Clinical Manifestations. Alzheimers Dement. 2024 Dec; 20 Suppl 3:e091377.
-
Vockert N, Machts J, Kleineidam L, Nemali A, Incesoy EI, Bernal J, Sch?tze H, Yakupov R, Peters O, Gref D, Schneider LS, Preis L, Priller J, Spruth EJ, Altenstein S, Schneider A, Fliessbach K, Wiltfang J, Rostamzadeh A, Glanz W, Teipel S, Kilimann I, Goerss D, Laske C, Munk MH, Spottke A, Roy N, Heneka MT, Brosseron F, Wagner M, Wolfsgruber S, Dobisch L, Dechent P, Hetzer S, Scheffler K, Zeidman P, Stern Y, Schott BH, Jessen F, D?zel E, Maass A, Ziegler G. Cognitive reserve against Alzheimer's pathology is linked to brain activity during memory formation. Nat Commun. 2024 Nov 13; 15(1):9815.
-
Soch J, Richter A, Kizilirmak JM, Sch?tze H, Ziegler G, Altenstein S, Brosseron F, Dechent P, Fliessbach K, Freiesleben SD, Glanz W, Gref D, Heneka MT, Hetzer S, Incesoy EI, Kilimann I, Kimmich O, Kleineidam L, Kuhn E, Laske C, Lohse A, L?sebrink F, Munk MH, Peters O, Preis L, Priller J, Ramirez A, Roeske S, Rostamzadeh A, Roy-Kluth N, Scheffler K, Schmid M, Schneider A, Spottke A, Spruth EJ, Teipel S, Wiltfang J, Jessen F, Wagner M, D?zel E, Schott BH. Single-value brain activity scores reflect both severity and risk across the Alzheimer's continuum. Brain. 2024 Nov 04; 147(11):3789-3803.
-
Ashendorf L, Withrow S, Gavett BE. The Neuropsychological Assessment Battery Driving Scenes Test in a Dementia Clinic. Arch Clin Neuropsychol. 2024 Oct 25; 39(7):872-880.
-
Fama R, Sassoon SA, M?ller-Oehring EM, Saranathan M, Pohl KM, Zahr NM, Pfefferbaum A, Sullivan EV. Anterior and posterior thalamic volumes differentially correlate with memory, attention, and motor processes in HIV infection and alcohol use disorder comorbidity. Brain Res Bull. 2024 Oct 15; 217:111085.
-
Kr?ger DM, Pena-Centeno T, Liu S, Park T, Kaurani L, Pradhan R, Huang YN, Risacher SL, Burkhardt S, Sch?tz AL, Wan Y, Shaw LM, Brodsky AS, DeStefano AL, Lin H, Schroeder R, Krunic A, Hempel N, Sananbenesi F, Blusztajn JK, Saykin AJ, Delalle I, Nho K, Fischer A. The plasma miRNAome in ADNI: Signatures to aid the detection of at-risk individuals. Alzheimers Dement. 2024 Nov; 20(11):7479-7494.